In addition to Serapinn product that has been successfully prescribed and used for a year and a half in the treatment of inflammation processes, and Serapinn forte launched in December 2017, Innventa has expanded its Otorhinolaryngology portfolio with two new products Laringinn and Rhinosinn. These two products are sprays for nose and throat used in [...]
Following ambitious new product introduction plan in H1 2018, Innventa have launched on Serbian, Bosnian an Montenegro market: Serapinn® Forte 120.000 SPU Serapinn® Forte 120.000 SPU is the extension of already very well established brand Serapinn, this time in form that due to double concentration of active ingredient (proteolitic enzyme Serrapeptase) presents the product of [...]
Fit to win 2018 Innventa kick-off meeting was held from January 27th to February 3rd in unique atmosphere of Costa Diadema cruiser on Western Mediterranean. The analyse of 2017 great achievements was done and ambitious goals for 2018strengthening are presented. In 2017 sales was 98,5% versus budget and 186,5% versus previous year, while budgeted sales growth [...]
